Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Sinovac’s Healive® Vaccine Not Responsible for Infant’s Death

publication date: Dec 31, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech (北京科兴生物制品有限公司) reported that Healive®, the company’s hepatitis A vaccine, has been cleared of any responsibility in the death of a two-year-old infant, who had been given the vaccine just two days before his death. According to discoveries made during an autopsy, the cause of death was myocarditis, an inflammation of the muscular part of the heart, which is usually caused by infection. Healive was not a factor in this problem. More details...

Stock Symbol: (NYSE Alternext US: SVA)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners